Alpha 2.0
Login Register
» Articles » PMID: 35519791

Neutrophil-to-Lymphocyte Ratio As a Predictor of Disease Severity and Mortality in Coronavirus Disease 2019: Prospective Study From Central India

Overview
Journal Cureus
Specialty Biomedical Engineering
Date 2022 May 6
PMID 35519791
Authors
Bharatsing D Rathod
Dnyanesh Amle
Rajashree S Khot
Kiran Kumar Prathipati
Prashant P Joshi
Affiliations
Soon will be listed here.
Abstract

Background: Clinical presentation of coronavirus disease 2019 (COVID-19) varies from an asymptomatic state to severe disease characterized by acute respiratory distress syndrome, respiratory failure, thrombosis, and multi-organ dysfunction syndrome. The neutrophil-to-lymphocyte ratio (NLR) has been reviewed as one of the laboratory factors that have been proposed to predict the severity of disease and mortality in COVID-19 pandemic.

Aim And Objectives: To evaluate the association between NLR and the disease severity and mortality in COVID-19.

Materials And Methods: After approval from Institutional Ethics Committee, this prospective cohort study was carried out in a tertiary-care teaching medical institute of Central India. COVID-19 patients of the age group 18 years and above admitted during the study period were included. Cases were categorized into four groups as asymptomatic (Group A), mild (Group B), moderate (Group C), and severe (Group D) based on clinical symptoms, respiratory rate, oxygen saturation, and chest imaging. NLR was calculated by doing a complete blood count at the time of hospitalization by the Mindray BC-6000 auto hematology analyzer. The outcome of the disease was classified as recovery and death during hospitalization. Receiver operating characteristic (ROC) curve analysis was used to assess the ability of NLR at admission to predict severe COVID-19 or mortality. Ordinal regression analysis was used to assess the impact of NLR on disease severity and mortality.

Results: Mean NLR was significantly higher in the severe COVID-19 group as compared to the mild/moderate group and in deceased as compared to discharged cases. ROC curve analysis revealed NLR to be an excellent predictor of disease severity as well as a prognostic parameter for risk of death. NLR was found to be a significant independent positive predictor for contracting the severe disease (Odd's ratio 1.396, 95% CI=1.112-1.753, p=0.004) and mortality (Odd's ratio 1.276, 95% CI=1.085-1.499, p=0.003).

Conclusion: High NLR was significantly associated with the disease severity and mortality in COVID-19.

Citing Articles

Effect of Elevated Neutrophil-to-Lymphocyte Ratio on Adverse Outcomes in Patients With Myocardial Infarction: A Systematic Review and Meta-Analysis.

Banahene N, Sinha T, Shaikh S, Zin A, Khreis K, Chaudhari S Cureus. 2024; 16(6):e61647.

PMID: 38966451 PMC: 11223570. DOI: 10.7759/cureus.61647.

Factors Associated with All-Cause 30-Day Mortality in Indonesian Inpatient COVID-19 Patients at Cipto Mangunkusumo National General Hospital.

Rinaldi I, Yulianti M, Yunihastuti E, Rajabto W, Irawan C, Sukrisman L J Clin Med. 2024; 13(10).

PMID: 38792539 PMC: 11122025. DOI: 10.3390/jcm13102998.

Monitoring the Efficacy of High-Flow Nasal Cannula Oxygen Therapy in Patients with Acute Hypoxemic Respiratory Failure in the General Respiratory Ward: A Prospective Observational Study.

Zhao Z, Chang M, Zhang T, Gow C Biomedicines. 2023; 11(11).

PMID: 38002067 PMC: 10669826. DOI: 10.3390/biomedicines11113067.

Receiver operating characteristic (ROC) to determine cut-off points of clinical and biomolecular markers to discriminate mortality in severe COVID-19 living at high altitude.

Velez-Paez J, Baldeon-Rojas L, Canadas Herrera C, Montalvo M, Jara F, Aguayo-Moscoso S BMC Pulm Med. 2023; 23(1):393.

PMID: 37848858 PMC: 10583315. DOI: 10.1186/s12890-023-02691-2.

Changes and Rate of Change in Neutrophil-Lymphocyte Ratio (∆NLR) as an Early Prognostic Marker for the Severity of Outcomes in Patients With COVID-19 and Its Applicability in Other Viral and Bacterial Diseases.

Jasti N, Mn L, Pothireddy N, Sankepalli M, Jagathkar G, Singh U Cureus. 2023; 15(7):e41774.

PMID: 37575788 PMC: 10416752. DOI: 10.7759/cureus.41774.

References
1.
Liu Y, Du X, Chen J, Jin Y, Peng L, Wang H . Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020; 81(1):e6-e12. PMC: 7195072. DOI: 10.1016/j.jinf.2020.04.002. View
2.
Williamson E, Walker A, Bhaskaran K, Bacon S, Bates C, Morton C . Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020; 584(7821):430-436. PMC: 7611074. DOI: 10.1038/s41586-020-2521-4. View
3.
Jimeno S, Ventura P, Castellano J, Garcia-Adasme S, Miranda M, Touza P . Prognostic implications of neutrophil-lymphocyte ratio in COVID-19. Eur J Clin Invest. 2020; 51(1):e13404. DOI: 10.1111/eci.13404. View
4.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View
5.
Kim S, Eliot M, Koestler D, Wu W, Kelsey K . Association of Neutrophil-to-Lymphocyte Ratio With Mortality and Cardiovascular Disease in the Jackson Heart Study and Modification by the Duffy Antigen Variant. JAMA Cardiol. 2018; 3(6):455-462. PMC: 6128503. DOI: 10.1001/jamacardio.2018.1042. View